1538. Who Will Benefit From Therapeutic Drug Monitoring of Ganciclovir?

BACKGROUND: Oral valganciclovir and intravenous ganciclovir are used for prophylaxis, treatment, and pre-emptive treatment of cytomegalovirus and human herpesvirus 6. It is important to estimate the exposure to these antivirals, as deviating levels can cause adverse events or induce acquired drug re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Martson, Anne-Grete, Sturkenboom, Marieke G G, Berger, Stefan P, Damman, Kevin, Verschuuren, Erik A M, Blokzijl, Hans, Bakker, Martijn, Span, Lambert F R, Touw, Daan J, van der Werf, Tjip S, Knoester, Marjolein, Alffenaar, Jan-Willem C
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809420/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1402
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars